Published in Cancer Weekly, April 29th, 1996
Researchers made the announced at the 87th Annual Meeting of the American Association for Cancer Research (AACR), held in Washington, D.C., April 20-24, 1996.
Based on promising results in earlier studies, researchers have launched a multicenter clinical trial to determine the vaccine's therapeutic potential in patients with advanced melanoma. Patients in this group are at high risk, with a 50- to 80-percent likelihood for cancer recurrence, and effective treatments are few.
"Early results suggest that tumor vaccines targeting the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.